Citigroup’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $157K | Sell |
9,794
-7,218
| -42% | -$115K | ﹤0.01% | 3454 |
|
|
2025
Q1 | $259K | Sell |
17,012
-14,001
| -45% | -$213K | ﹤0.01% | 3290 |
|
|
2024
Q4 | $629K | Buy |
31,013
+13,746
| +80% | +$279K | ﹤0.01% | 2877 |
|
|
2024
Q3 | $444K | Buy |
17,267
+11,541
| +202% | +$297K | ﹤0.01% | 3059 |
|
|
2024
Q2 | $73.6K | Sell |
5,726
-3,081
| -35% | -$39.6K | ﹤0.01% | 3638 |
|
|
2024
Q1 | $202K | Sell |
8,807
-34,291
| -80% | -$785K | ﹤0.01% | 3294 |
|
|
2023
Q4 | $1.13M | Buy |
43,098
+43,089
| +478,767% | +$1.13M | ﹤0.01% | 2063 |
|
|
2023
Q3 | $247 | Hold |
9
| – | – | ﹤0.01% | 4531 |
|
|
2023
Q2 | $268 | Sell |
9
-84,987
| -100% | -$2.53M | ﹤0.01% | 4657 |
|
|
2023
Q1 | $1.6M | Buy |
84,996
+84,973
| +369,448% | +$1.6M | ﹤0.01% | 1682 |
|
|
2022
Q4 | $231 | Sell |
23
-68
| -75% | -$683 | ﹤0.01% | 4785 |
|
|
2022
Q3 | $2K | Sell |
91
-140
| -61% | -$3.08K | ﹤0.01% | 4732 |
|
|
2022
Q2 | $10K | Buy |
231
+61
| +36% | +$2.64K | ﹤0.01% | 4635 |
|
|
2022
Q1 | $17K | Sell |
170
-540
| -76% | -$54K | ﹤0.01% | 4502 |
|
|
2021
Q4 | $109K | Buy |
710
+582
| +455% | +$89.3K | ﹤0.01% | 3927 |
|
|
2021
Q3 | $17K | Buy |
128
+77
| +151% | +$10.2K | ﹤0.01% | 4548 |
|
|
2021
Q2 | $7K | Buy |
+51
| New | +$7K | ﹤0.01% | 5095 |
|